Tiziana Life Sciences Ltd. Company Profile
NASDAQ: TLSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 1.13 0.00%
Tiziana Life Sciences at a glance
Tiziana Life Sciences Ltd. (NASDAQ: TLSA) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in London, United Kingdom. Tiziana Life Sciences is led by Dr. Ivor R. Elrifi Ph.D. and employs about 10 people. The company's shares have traded publicly since 2018.
At a market capitalization of $141.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001723069, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Tiziana Life Sciences do?
Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops Foralumab TZLS-401, a human anti-CD3 monoclonal antibody, which is Phase II clinical trial for the treatment of non-active secondary progressive multiple sclerosis, Alzheimer's disease, multi system atrophy, and amyotrophic lateral sclerosis; and TZLS-501, a human anti-IL-6R monoclonal antibody for the treatment of autoimmune and inflammatory diseases. The company is headquartered in London, the United Kingdom.
Business description based on the company's public filings.
Company information
- Legal name
- Tiziana Life Sciences Ltd.
- Ticker
- NASDAQ: TLSA
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Ivor R. Elrifi Ph.D.
- Employees
- 10
- Headquarters
- 14/15 Conduit Street, London, United Kingdom
- Phone
- 44 20 7495 2379
- Website
- tizianalifesciences.com
- IPO year
- 2018
- Market cap
- $141.26M
- SEC CIK
- 0001723069
Companies similar to Tiziana Life Sciences
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RNAAtrium Therapeutics Inc. | 8.26 | +4.16% | $141.29M | vs TLSA |
| OGIOrganigram Global Inc. | 0.9511 | -0.93% | $137.10M | vs TLSA |
| BGMBGM Group Ltd. Class A | 9.96 | +6.07% | $133.01M | vs TLSA |
| SPRBSpruce Biosciences Inc. | 45.54 | +2.57% | $130.88M | vs TLSA |
| NERVMinerva Neurosciences Inc | 3.22 | -1.53% | $153.75M | vs TLSA |
| VRXAVeraxa Biotech AG | 1.09 | -9.17% | $154.13M | vs TLSA |
| KRROKorro Bio Inc. | 10.58 | +0.86% | $155.80M | vs TLSA |
| MSLESatellos Bioscience Inc. | 7.35 | -3.74% | $155.83M | vs TLSA |